143 related articles for article (PubMed ID: 27923834)
1. CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.
Manfroi B; McKee T; Mayol JF; Tabruyn S; Moret S; Villiers C; Righini C; Dyer M; Callanan M; Schneider P; Tzankov A; Matthes T; Sturm N; Huard B
Cancer Res; 2017 Mar; 77(5):1097-1107. PubMed ID: 27923834
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness.
Schwaller J; Schneider P; Mhawech-Fauceglia P; McKee T; Myit S; Matthes T; Tschopp J; Donze O; Le Gal FA; Huard B
Blood; 2007 Jan; 109(1):331-8. PubMed ID: 17190854
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomas.
Grégoire M; Guilloton F; Pangault C; Mourcin F; Sok P; Latour M; Amé-Thomas P; Flecher E; Fest T; Tarte K
Oncotarget; 2015 Jun; 6(18):16471-87. PubMed ID: 26158216
[TBL] [Abstract][Full Text] [Related]
4. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
Löfström B; Backlin C; Pettersson T; Lundberg IE; Baecklund E
J Rheumatol; 2011 Sep; 38(9):1891-7. PubMed ID: 21724695
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling.
Nie M; Yang L; Bi X; Wang Y; Sun P; Yang H; Liu P; Li Z; Xia Y; Jiang W
Clin Cancer Res; 2019 Mar; 25(6):1867-1879. PubMed ID: 30446590
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.
Singh RR; Kim JE; Davuluri Y; Drakos E; Cho-Vega JH; Amin HM; Vega F
Leukemia; 2010 May; 24(5):1025-36. PubMed ID: 20200556
[TBL] [Abstract][Full Text] [Related]
8. Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.
Muto M; Manfroi B; Suzuki H; Joh K; Nagai M; Wakai S; Righini C; Maiguma M; Izui S; Tomino Y; Huard B; Suzuki Y
J Am Soc Nephrol; 2017 Apr; 28(4):1227-1238. PubMed ID: 27920152
[TBL] [Abstract][Full Text] [Related]
9. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
[TBL] [Abstract][Full Text] [Related]
10. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils.
Scapini P; Bazzoni F; Cassatella MA
Immunol Lett; 2008 Feb; 116(1):1-6. PubMed ID: 18155301
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
12. The source of APRIL up-regulation in human solid tumor lesions.
Mhawech-Fauceglia P; Kaya G; Sauter G; McKee T; Donze O; Schwaller J; Huard B
J Leukoc Biol; 2006 Oct; 80(4):697-704. PubMed ID: 16793914
[TBL] [Abstract][Full Text] [Related]
13. The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis.
Sandberg WJ; Otterdal K; Gullestad L; Halvorsen B; Ragnarsson A; Frøland SS; Damås JK; Oie E; Aukrust P; Hansson GK; Yndestad A
Thromb Haemost; 2009 Oct; 102(4):704-10. PubMed ID: 19806256
[TBL] [Abstract][Full Text] [Related]
14. Expression of programmed cell death 1/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas.
Liu Y; Ma J; Yu K; Li M; Liu F; Yan Q; Wang Z; Guo S
Pathol Res Pract; 2018 Apr; 214(4):507-512. PubMed ID: 29598887
[TBL] [Abstract][Full Text] [Related]
15. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.
Quan L; Chen X; Liu A; Zhang Y; Guo X; Yan S; Liu Y
PLoS One; 2015; 10(9):e0136476. PubMed ID: 26361042
[TBL] [Abstract][Full Text] [Related]
16. Award Winner in the Young Investigator Category, 2017 Society for Biomaterials Annual Meeting and Exposition, Minneapolis, MN, April 05-08, 2017: Lymph node stiffness-mimicking hydrogels regulate human B-cell lymphoma growth and cell surface receptor expression in a molecular subtype-specific manner.
Apoorva FNU; Tian YF; Pierpont TM; Bassen DM; Cerchietti L; Butcher JT; Weiss RS; Singh A
J Biomed Mater Res A; 2017 Jul; 105(7):1833-1844. PubMed ID: 28177577
[TBL] [Abstract][Full Text] [Related]
17. A proliferation-inducing ligand (APRIL) in neutrophils of patients with oral cavity squamous cell carcinoma.
Jabłońska E; Wawrusiewicz-Kurylonek N; Garley M; Ratajczak-Wrona W; Antonowicz B; Dziemiańczyk-Pakieła D; Jabłoński J; Krętowski A; Grabowska SZ
Eur Cytokine Netw; 2012; 23(3):93-100. PubMed ID: 23010686
[TBL] [Abstract][Full Text] [Related]
18. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Papoudou-Bai A; Kitsoulis P; Kanavaros P
Anticancer Res; 2005; 25(1A):347-62. PubMed ID: 15816558
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma.
Zhou X; Guo S; Shi Y
Sci Rep; 2022 Feb; 12(1):2817. PubMed ID: 35181719
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressive role of inhibin βA in diffuse large B-cell lymphoma.
Jiang L; Si T; Yu M; Zeng X; Morse HC; Lu Y; Ouyang G; Zhou JX
Leuk Lymphoma; 2018 May; 59(5):1202-1212. PubMed ID: 28877610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
